| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
| mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.001 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.002 |
| mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |